Korean Journal of Audiology (대한청각학회지)

The Korean Audiology Society (대한청각학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features and Hearing Outcomes of Sudden Sensorineural Hearing Loss in Diabetic Patients

  • Ju, Yeo Rim (Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital) ;
  • Park, Hyoung-sik (Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital) ;
  • Lee, Min Young (Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital) ;
  • Jung, Jae Yun (Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital) ;
  • Choi, Ji Eun (Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University Hospital)
  • Received : 2020.05.30
  • Accepted : 2020.08.27
  • Published : 2021.01.20
⟨ Previous Next ⟩

Abstract

Background and Objectives: This study aimed to evaluate the clinical features and the clinical factors associated with prognosis of sudden sensorineural hearing loss (SSNHL) in diabetic patients. Subjects and Methods: Forty-nine diabetic with unilateral SSNHL were retrospectively included. All patients received systemic high dose steroid therapy within one month after onset and had more than one month of follow-up audiogram. The basic characteristics of the patients, initial and follow-up audiograms, laboratory data, and methods of steroid treatment were collected. Results: Compared to reference values in healthy subjects, 79%, 55%, and 45% of the patients had higher values of mean neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and lymphocyte-monocyte ratio (LMR), respectively. Older patients had significantly less degree of hearing loss, but they also had significantly worse hearing thresholds in the unaffected ear. After steroid treatment, less than half patients (47%) showed hearing recovery. Simultaneous intratympanic dexamethasone (ITD) injections with systemic steroid did not confer an additional hearing gain or an earlier recovery rate in diabetic patients with SSNHL. In the multivariate analysis, initial hearing thresholds of affected ear and timing of steroid treatment were significantly associated with hearing prognosis in diabetic patients with SSNHL. Conclusions: Diabetic patients with SSNHL tended to have increased NLR, LMR, and PLR, which are reported to be associated with microvascular angiopathy. Simultaneous ITD injections to improve hearing recovery in diabetic patients with SSNHL seems unnecessary.

Keywords

References

  1. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am 1996;29:393-405. https://doi.org/10.1016/s0030-6665(20)30362-5
  2. Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2013;2013:CD003998.
  3. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone+high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453-60. https://doi.org/10.1097/MAO.0b013e318168da7a
  4. Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 2011;32:774-9. https://doi.org/10.1097/MAO.0b013e31821fbdd1
  5. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973-88. https://doi.org/10.1007/s001250100001
  6. Jorgensen MB. The inner ear in diabetes mellitus. Histological studies. Arch Otolaryngol 1961;74:373-81. https://doi.org/10.1001/archotol.1961.00740030382003
  7. Kim HJ, Lee YJ, Kang HT, Lee SA, Lee JD, Kim BG. Comparison of intratympanic, systemic, and combined steroid therapies for sudden sensorineural hearing loss in patients with diabetes mellitus. Korean J Otorhinolaryngol-Head Neck Surg 2019;62:379-84. https://doi.org/10.3342/kjorl-hns.2018.00892
  8. Han CS, Park JR, Boo SH, Jo JM, Park KW, Lee WY, et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg 2009;141:572-8. https://doi.org/10.1016/j.otohns.2009.06.084
  9. Weng SF, Chen YS, Liu TC, Hsu CJ, Tseng FY. Prognostic factors of sudden sensorineural hearing loss in diabetic patients. Diabetes Care 2004;27:2560-1.
  10. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467-73. https://doi.org/10.1016/s0030-6665(20)32783-3
  11. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine (Baltimore) 2018;97:e11138. https://doi.org/10.1097/md.0000000000011138
  12. Kurien M, Thomas K, Bhanu TS. Hearing threshold in patients with diabetes mellitus. J Laryngol Otol 1989;103:164-8. https://doi.org/10.1017/S0022215100108345
  13. Wilson WR, Laird N, Moo-Young G, Soeldner JS, Kavesh DA, MacMeel JW. The relationship of idiopathic sudden hearing loss to diabetes mellitus. Laryngoscope 1982;92:155-60. https://doi.org/10.1002/lary.1982.92.2.155
  14. Nemati S, Hassanzadeh R, Mehrdad M, Sajedi Kia S. Hearing status in patients with type 2 diabetes mellitus according to blood-sugar control: a comparative study. Iran J Otorhinolaryngol 2018;30:209-18.
  15. Srinivas CV, Shyamala V, Shiva Kumar BR. Clinical study to evaluate the association between sensorineural hearing loss and diabetes mellitus in poorly controlled patients whose HbA1c >8. Indian J Otolaryngol Head Neck Surg 2016;68:191-5. https://doi.org/10.1007/s12070-016-0973-5
  16. Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz J Otorhinolaryngol 2005;71:208-14. https://doi.org/10.1016/S1808-8694(15)31312-4
  17. Makishima K, Tanaka K. Pathological changes of the inner ear and central auditory pathway in diabetics. Ann Otol Rhinol Laryngol 1971;80:218-28. https://doi.org/10.1177/000348947108000208
  18. Costa OA. Inner ear pathology in experimental diabetes. Laryngoscope 1967;77:68-75. https://doi.org/10.1288/00005537-196701000-00005
  19. Jun HJ, Hwang SY, Lee SH, Lee JE, Song JJ, Chae S. The prevalence of hearing loss in South Korea: data from a population-based study. Laryngoscope 2015;125:690-4. https://doi.org/10.1002/lary.24913
  20. Weng SF, Chen YS, Hsu CJ, Tseng FY. Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 2005;115:1676-80. https://doi.org/10.1097/01.mlg.0000184790.91675.e3
  21. Chen L, Zhang G, Zhang Z, Wang Y, Hu L, Wu J. Neutrophil-to-lymphocyte ratio predicts diagnosis and prognosis of idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e12492. https://doi.org/10.1097/md.0000000000012492
  22. Lou M, Luo P, Tang R, Peng Y, Yu S, Huang W, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord 2015;15:9. https://doi.org/10.1186/s12902-015-0002-9
  23. Hussain M, Babar MZM, Akhtar L, Hussain MS. Neutrophil lymphocyte ratio (NLR): a well assessment tool of glycemic control in type 2 diabetic patients. Pak J Med Sci 2017;33:1366-70.
  24. Dziedzic T. Systemic inflammation as a therapeutic target in acute ischemic stroke. Expert Rev Neurother 2015;15:523-31. https://doi.org/10.1586/14737175.2015.1035712
  25. Ermutlu G, Suslu N, Yilmaz T, Sarac S. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. Eur Arch Otorhinolaryngol 2017;274:3585-91. https://doi.org/10.1007/s00405-017-4691-8
  26. Ahn JH, Kim TY, Kim YJ, Han MW, Yoon TH, Chung JW. Lipoprostaglandin E1 in combination with steroid therapy is effective for treatment of sudden sensorineural hearing loss in Korean patients with type 2 diabetes. Diabet Med 2006;23:1339-43. https://doi.org/10.1111/j.1464-5491.2006.01993.x
  27. Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol 2008;128:128-31. https://doi.org/10.1080/00016480701477602
  28. Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope 1984;94:647-61.
  29. Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;145:1016-21. https://doi.org/10.1177/0194599811418169
  30. Yoo MH, Lim WS, Park JH, Kwon JK, Lee TH, An YH, et al. Simultaneous versus sequential intratympanic steroid treatment for severe-to-profound sudden sensorineural hearing loss. Audiol Neurootol 2016;21:399-405. https://doi.org/10.1159/000464095